XBIO News Alert Xenetic Biosciences Inc. (XBIO) 0.5102 09/28/2014

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

ARK Venture Fund Invests in Umoja's Innovative Cancer Research Cathie Wood's ARK Venture Fund has made a notable investment in Umoja's Series C funding round, marking a significant milestone for the biotech company. Umoja is dedicated to pioneering a transformative approach to cancer treatment, focusing on enhancing the patient's immune response through novel techniques....

Hooker Furnishings' Second Quarter Performance Hooker Furnishings Corporation (NASDAQ: HOFT), a well-established name in the home furnishings industry for more than a century, recently revealed its financial results for the second quarter of fiscal 2025. The company demonstrated resilience in the face of challenging market conditions. Sales Performance Insights Typically...

Pulmonx Achieves Record Financial Success in 2024 Pulmonx Corporation (Nasdaq: LUNG) has made significant strides in its financial performance, demonstrating a remarkable growth trajectory throughout 2024. This globally recognized leader in minimally invasive lung disease treatments reported promising results that highlight its strong business model and commitment to...

Blue Hat Interactive Entertainment Technology Engages in Direct Share Offering Recently, Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) made headlines by announcing its entry into securities purchase agreements allowing it to raise an impressive $4.3 million. This initiative is aimed at bolstering the company's financial stability and enhancing its market...

PTx Trimble Triumphs with OutRun at the Davidson Prize OutRun Autonomous Grain Cart Now Available in the U.S. PTx Trimble, a collaboration between AGCO and Trimble that started in 2024, has made headlines by launching OutRun, a revolutionary autonomous grain cart that has just clinched the prestigious Davidson Prize at Commodity Classic 2025. This accolade recognizes...